This paper is in the following e-collection/theme issue:

Breast Cancer (290) Chatbots and Conversational Agents (740) Innovations and Technology in Cancer Care (531) Patient Education for Cancer (227) Cancer Self-Management (91) Innovations in Cancer Diagnostic and Decision Support (109) Generative Language Models Including ChatGPT (708)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68426, first published .
Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study

Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study

Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study

Authors of this article:

Sebastian Daniel Boie1 Author Orcid Image ;   Esther Glastetter1 Author Orcid Image ;   Michael Patrick Lux2 Author Orcid Image ;   Felix Balzer3 Author Orcid Image ;   Christof von Kalle4 Author Orcid Image ;   Christian Lenz1 Author Orcid Image ;   Ulrike Müller1 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Sebastian Daniel Boie   1 , PhD ;   Esther Glastetter   1 , PhD ;   Michael Patrick Lux   2 , MD, MBA ;   Felix Balzer   3 , PhD ;   Christof von Kalle   4 , MD ;   Christian Lenz   1 , MD ;   Ulrike Müller   1 , PhD

1 Pfizer Pharma GmbH, Berlin, Germany

2 Department for Gynecology and Obstetrics, St. Louise Women's Hospital, Paderborn, St. Josefs Women's Hospital, Salzkotten, St. Vincenz Clinics, Salzkotten + Paderborn, Germany

3 Institute of Medical Informatics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

4 Clinical Study Center, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany

Corresponding Author: